The Menicon Bloom myopia control management system has been described as “the first holistic approach to myopia control focusing on helping practitioners manage and monitor their patients more effectively”.
The first product within the Bloom system, and first CE-approved orthokeratology contact lens therapy for myopia control management, is Menicon Bloom Night. This therapy involves the overnight wear of a specially designed orthokeratology contact lens, manufactured in hyper oxygen-permeable Menicon Z material that ensures optimal corneal oxygenation for comfortable and safe contact lens wear.
Dr Hidenari Tanaka, Menicon CEO said, “We are delighted with the major breakthrough achieved with the approval and launch of our Menicon Bloom Myopia Control Management System. We are confident that our continuing commitment to myopia control management will position Menicon as a key contributor in this field and strengthen our position as a global vision care company.
“It is our belief that the growing prevalence of worldwide myopia progression requires a comprehensive and educated response and we have identified this as a major initiative within our development programs. As a pioneer of contact lenses, we will develop our myopia control business based on our accumulated technology, products and services, and contribute to society by supporting eye care professionals in managing the fast-growing incidence of myopia.”
Menicon has developed an Easyfit software system, which guides the optometrist when fitting Menicon Bloom Night. Additionally, a specially designed smartphone application, the Bloom App, has been developed to enhance monitoring and communications between optometrists and patients.
Menicon Bloom Night is complemented by Bloom Care and Bloom Progent, Menicon’s established lens cleaning solutions, to ensure proper lens hygiene and safety for patients. The system has been successfully used in the Netherlands since June 2019.
Contact: Menicon Account Manager